Venous thromboembolism (VTE) is an increasingly frequent complication of cancer and its treatments. One in five cancer patients are estimated to develop venous and arterial events …
GC Connolly, AA Khorana - Thrombosis research, 2010 - Elsevier
Cancer patients are well-known to be at increased risk of venous thromboembolism (VTE). However, the risk varies widely between patients and over the natural history of malignancy …
Rates of venous thromboembolism (VTE) vary substantially between cancer patients. Multiple clinical risk factors including primary site of cancer and systemic therapy, and …
AA Khorana, GC Connolly - Journal of Clinical Oncology, 2009 - ascopubs.org
Purpose Patients with cancer are increasingly at risk for venous thromboembolism (VTE). Rates of VTE, however, vary markedly among patients with cancer. Design This review …
M Gomes, AA Khorana - Seminars in thrombosis and …, 2014 - thieme-connect.com
Patients with active malignancy are well-known to be at higher risk for venous thromboembolism (VTE). However, the risk of VTE varies considerably between patients and …
A Falanga, L Russo - Hämostaseologie, 2012 - thieme-connect.com
Cancer is associated with a fourfold increased risk of venous thromboembolism (VTE). The risk of VTE varies according to the type of malignancy (ie pancreatic cancer, brain cancer …
J Costa, A Araújo - Seminars in Thrombosis and Hemostasis, 2021 - thieme-connect.com
Cancer-related venous thromboembolism (VTE) remains a major health problem, accounting for at least 18% of all cases of VTE. Cancer patients with VTE have worse …
T Sousou, A Khorana - Hamostaseologie, 2009 - europepmc.org
Venous thromboembolism (VTE) is a known complication of cancer which impacts on patient mortality and quality of life. Despite the known deleterious effects of VTE, the benefits of …
Venous thromboembolism (VTE) represents a major challenge in the management of patients with cancer. The malignant phenotype is associated with derangements in the …